More frequent metabolic panels help track the complex changes across glucose, lipid, and hepatic markers that triple-agonist therapy produces
These changes can help support healthier eating patterns and steady weight management when combined with proper nutrition and physical activity
While originally developed for blood sugar management, GLP-1 and GIP therapies are now commonly used under medical supervision to support metabolic health, weight management, and body composition in individuals who meet appropriate criteria
Shanghai University of Traditional Chinese Medicine Clinical Research Backbone Training Program (2023LCRC20)
Patients also report acid reflux, stomach pain, vomiting, and diarrhea
In the same way as semaglutide, this drug is administered subcutaneously